Clinical Trial Update: 6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating 6,8-Bis(Benzylthio)Octanoic Acid in combination with Cytarabine and Daunorubicin hydrochloride for untreated older adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• 6,8-Bis(Benzylthio)Octanoic Acid (6,8-Bis(Benzylthio)Octanoic Acid)
• CYTARABINE (CYTARABINE)
• Daunorubicin hydrochloride (daunorubicin hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Untreated Adult Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: WITHDRAWN